Reuters: Allergan eyes new takeover bid for Shire

Allergan (AGN) is preparing to approach Shire (SHPG) about a potential takeover after holding talks in recent months that didn't work out, but AGN is still interested, Reuters reports.

AGN, which has since received a $47B takeover offer from Valeant Pharma (VRX) teamed up with activist investor Bill Ackman, is said to be planning a fresh approach to the Irish drugmaker.

An Allergan-Shire combination would create a company with a market value of nearly $72B and annual sales of more than $11B, not to mention help AGN in its defense against VRX.

This was corrected on 04/29/2014 at 08:00 AM.
From other sites
Comments (2)
  • fidelity comment
    , contributor
    Comments (257) | Send Message
    Wrong ticker, you used vertex's.
    28 Apr 2014, 06:38 PM Reply Like
  • Adlai Pappy
    , contributor
    Comments (21) | Send Message
    Ticker VRX
    28 Apr 2014, 09:05 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs